Position in LLY
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$4,343,136
+$917,913 QoQ
Shares Held
3,621
-2.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
2.72%
of 13F equity value
Holder Rank
#1,824
of 4,605 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Carr Financial Group Corp holds $8,711,748 across 6 Drug Manufacturers - General names. LLY ranks #1 (49.9% of the industry book) .
All Filings in LLY
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,343,136 | 3,621 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $3,425,223 | 3,724 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $3,981,689 | 3,705 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $3,051,237 | 3,999 | Shares | Sole | 2025-10-08 | |
| 2025-06-30 | $2,606,748 | 3,344 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $2,699,899 | 3,269 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $2,817,028 | 3,649 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $3,242,540 | 3,660 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $3,707,531 | 4,095 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $3,164,741 | 4,068 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $2,556,687 | 4,386 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $2,355,852 | 4,386 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $2,096,340 | 4,470 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $1,535,087 | 4,470 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $1,745,056 | 4,770 | Shares | Sole | 2023-02-13 | |
| No filing history on record for this holder in this stock. | ||||||